Hyseq will expand into a free-standing, partial two-story building next door to the company's corporate headquarters at 670 Almador, where it will continue to occupy 60,000-sf. Hyseq is currently renovating the space for R&D, with a move-in date projected for 2002.
The company was represented by CRESA Partners, which recently negotiated Bay Area leases for biotech companies, including XenoPort, Aerogen and Perlegen. Mark Moser was the agent who negotiated the lease.
Hyseq, a public company, uses genomics, the study of genes and their functions, to develop pharmaceuticals. Insignia ESG represented the building owner.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
